Susquehanna International Group
PHIOW

Susquehanna International Group’s Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 PHIOW Stock Holding History

Susquehanna International Group’s Portfolio PHIOW Stock Details PHIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,591
Closed -$4K – 11988
2020
Q3 		$4K Buy
24,591
+7,022
+40% +$1.32K ﹤0.01% 10451
2020
Q2 		$3K Buy
+17,569
New +$2.19K ﹤0.01% 10014
2020
Q1 		– Sell
-50,888
Closed -$1K – 11171
2019
Q4 		$1K Buy
50,888
+565
+1% +$31 ﹤0.01% 9599
2019
Q3 		$1K Buy
50,323
+100
+0.2% +$4 ﹤0.01% 10069
2019
Q2 		$2K Buy
50,223
+32,860
+189% +$940 ﹤0.01% 10122
2019
Q1 		$0 Sell
17,363
-15,300
-47% -$542 ﹤0.01% 10217
2018
Q4 		$1K Buy
+32,663
New +$1.3K ﹤0.01% 8811

Other funds holding PHIOW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's PHIOW Position: Q4 2020 in Review

Susquehanna International Group sold out of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) in Q4 2020, closing a stake of 24,591 shares — an estimated $4K sold.

Susquehanna International Group first reported a position in PHIOW in Q4 2018 and held it in 7 quarters. The position peaked at $4K in Q3 2020. 3 funds tracked by Wall St. Rank hold PHIOW as of Q4 2020.

  • Susquehanna International Group reported no remaining Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 position as of Q4 2020 after selling out during the quarter.
  • Susquehanna International Group sold 24,591 Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 shares in Q4 2020, an estimated $4K.
  • Susquehanna International Group first reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in Q4 2018 and held it in 7 quarters.
  • Susquehanna International Group's Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 position peaked at $4K in Q3 2020.
  • 3 funds tracked by Wall St. Rank held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 as of Q4 2020.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.